retatrutide clinical trials weight loss This data from Phase 3 for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce New Phase 3 retatrutide data

As a result, investigators have increasingly explored whether GLP-1 therapy might confer protection against colorectal neoplasia, either as a direct biological effect or as a consequence of improved metabolic health

Made with natural fruit powders, coconut water powder, and Himalayan Pink Salt

4 In TRANSCEND-T2D-1, Lillys first Phase 3 trial in adults with type 2 diabetes (537 participants, 40 weeks), retatrutide produced 16.8% weight loss at the 12 mg dose

More than 40 peer-reviewed studies have featured or evaluated Nooms methods, demonstrating that cognitive tools and structured habit change lead to better long-term outcomes